Enveric Biosciences (NASDAQ: ENVB) is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.

Biotechnology

Enveric Bio

Joseph Tucker

Kevin Coveney

Peter Facchini

The Leadership Team at Enveric Bio is responsible for setting the strategic vision and guiding the company's mission to develop innovative cannabinoid-based therapies for cancer patients. This team oversees research and development initiatives, fosters collaborations, and ensures alignment with the organization's patient-centric goals while driving growth and securing funding to advance the company's therapeutic pipeline.

Leadership Team

About

Team members

Other teams at Enveric Bio

Scientific Advisors Team